Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Novavax (NVAX) concluded the recent trading session at $9.59, signifying a +1.36% move from its prior day's close.

Shares of Novavax Inc. NVAX rose 2.96% to $9.74 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 1.14% to ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the ...

Short interest data from late June 2026 highlights deeply divided investor sentiment across the healthcare sector. Strong bearish bets remain heavily concentrated in speculative biotech plays like ...